Related Experiment Video
Updated: Aug 4, 2025
Continuous Fluorescence-Based Endonuclease-Coupled DNA Methylation Assay to Screen for DNA Methyltransferase Inhibitors
Published on: August 5, 2022
Small molecule inhibitors for cancer metabolism: promising prospects to be explored
Dan Liu1, HongPing Wang1, XingXing Li1
1Department of Pharmacy, The First Affiliated Hospital of Army Medical University, Chongqing, 400038, China.
Background:
Abnormal metabolism is the main hallmark of cancer, and cancer metabolism plays an important role in tumorigenesis, metastasis, and drug resistance. Therefore, studying the changes of tumor metabolic pathways is beneficial to find targets for the treatment of cancer diseases. The success of metabolism-targeted chemotherapy suggests that cancer metabolism research will provide potential new targets for the treatment of malignant tumors.
Purpose:
The aim of this study was to systemically review recent research findings on targeted inhibitors of tumor metabolism. In addition, we summarized new insights into tumor metabolic reprogramming and discussed how to guide the exploration of new strategies for cancer-targeted therapy.
Conclusion:
Cancer cells have shown various altered metabolic pathways, providing sufficient fuel for their survival. The combination of these pathways is considered to be a more useful method for screening multilateral pathways. Better understanding of the clinical research progress of small molecule inhibitors of potential targets of tumor metabolism will help to explore more effective cancer treatment strategies.
Insights
Cancer cells exhibit altered metabolism, crucial for their growth and survival. Targeting these metabolic pathways offers promising strategies for developing new cancer therapies.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Research
Background:
- Abnormal cancer metabolism is a key driver of tumor growth, metastasis, and drug resistance.
- Understanding tumor metabolic pathways is crucial for identifying novel cancer treatment targets.
- Metabolism-targeted chemotherapy has shown success, highlighting research potential in malignant tumors.
Purpose of the Study:
- To conduct a systematic review of research on targeted inhibitors of tumor metabolism.
- To summarize new insights into tumor metabolic reprogramming.
- To discuss strategies for guiding new cancer-targeted therapies.
Main Methods:
- Systematic literature review of recent findings.
- Analysis of tumor metabolic reprogramming insights.
- Discussion of clinical research progress and therapeutic strategies.
Main Results:
- Cancer cells display diverse altered metabolic pathways essential for survival.
- Combined pathway analysis is effective for screening multiple targets.
- Small molecule inhibitors targeting tumor metabolism show clinical research progress.
Conclusions:
- Altered cancer cell metabolism provides fuel for tumor survival.
- Integrated pathway analysis aids in comprehensive target screening.
- Understanding inhibitor progress can lead to more effective cancer treatments.
Related Concept Videos
02:57Targeted Cancer Therapies
There are several types of targeted therapies against...
01:46Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
02:34Inhibition of Cdk Activity
02:53Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
01:26Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...